TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
Go back to TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility| ALEXANDRIA RE EQUITIES (NYSE: ARE) | Delayed: 51.57 -0.71 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.28 | 52 Week High | $114.67 | |||
| Open | $52.49 | 52 Week Low | $70.69 | |||
| Day High | $52.81 | P/E | 34.15 | |||
| Day Low | $51.54 | EPS | $1.51 | |||
| Volume | 1,323,507 | |||||
| (NASDAQ: AUTL) | Delayed: 2.34 -0.02 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $ | |||
| Open | $2.35 | 52 Week Low | $ | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.28 | EPS | $ | |||
| Volume | 1,436,887 | |||||
| (NASDAQ: TCRR) | Delayed: 1.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $ | |||
| Open | $3.63 | 52 Week Low | $ | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.48 | EPS | $ | |||
| Volume | 52,452 | |||||
